Conmed (CNMD) Equity Average (2016 - 2025)
Historic Equity Average for Conmed (CNMD) over the last 15 years, with Q4 2025 value amounting to $1.0 billion.
- Conmed's Equity Average rose 769.07% to $1.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.0 billion, marking a year-over-year increase of 769.07%. This contributed to the annual value of $997.9 million for FY2025, which is 1106.77% up from last year.
- Latest data reveals that Conmed reported Equity Average of $1.0 billion as of Q4 2025, which was up 769.07% from $1.0 billion recorded in Q3 2025.
- Conmed's 5-year Equity Average high stood at $1.0 billion for Q4 2025, and its period low was $694.7 million during Q3 2022.
- For the 5-year period, Conmed's Equity Average averaged around $829.5 million, with its median value being $787.8 million (2022).
- Its Equity Average has fluctuated over the past 5 years, first crashed by 739.09% in 2022, then soared by 1626.26% in 2024.
- Quarter analysis of 5 years shows Conmed's Equity Average stood at $770.6 million in 2021, then decreased by 5.14% to $730.9 million in 2022, then increased by 11.53% to $815.2 million in 2023, then grew by 16.26% to $947.8 million in 2024, then increased by 7.69% to $1.0 billion in 2025.
- Its Equity Average stands at $1.0 billion for Q4 2025, versus $1.0 billion for Q3 2025 and $990.3 million for Q2 2025.